Seasonal and pandemic influenza H1N1 viruses induce differential expression of SOCS-1 and RIG-I genes and cytokine/chemokine production in macrophages

doi:10.1016/j.cyto.2013.01.018

Cytokine

Volume 62, Issue 1, April 2013, Pages 151-159

https://doi.org/10.1016/j.cyto.2013.01.018 Get rights and content

Abstract

Background

Infection with pandemic (pdm) A/H1N1 virus induces high levels of pro-inflammatory mediators in blood and lungs of experimental animals and humans.

Methods

To compare the involvement of seasonal A/PR/8/34 and pdm A/H1N1 virus strains in the regulation of inflammatory responses, we analyzed the changes in the whole-genome expression induced by these strains in macrophages and A549 epithelial cells. We also focused on the functional implications (cytokine production) of the differential induction of suppressors of cytokine signaling (SOCS)-1, SOCS-3, retinoid-inducible gene (RIG)-I and interferon receptor 1 (IFNAR1) genes by these viral strains in early stages of the infection.

Results

We identified 130 genes differentially expressed by pdm A/H1N1 and A/PR/8/34 infections in macrophages. mRNA levels of SOCS-1 and RIG-I were up-regulated in macrophages infected with the A/PR/8/34 but not with pdm A/H1N1 virus. mRNA levels of SOCS-3 and IFNAR1 induced by A/PR/8/34 and pdm A/H1N1 strains in macrophages, as well as in A549 cells were similar. We found higher levels of IL-6, TNF-α, IL-10, CCL3, CCL5, CCL4 and CXCL8 (p < 0.05) in supernatants from cultures of macrophages infected with the pdm A/H1N1 virus compared to those infected with the A/PR/8/34 strain, coincident with the lack of SOCS-1 and RIG-I expression. In contrast, levels of INF-α were higher in cultures of macrophages 48 h after infection with the A/PR/8/34 strain than with the pdm A/H1N1 virus.

Conclusions

These findings suggest that factors inherent to the pdm A/H1N1 viral strain may increase the production of inflammatory mediators by inhibiting SOCS-1 and modifying the expression of antiviral immunity-related genes, including RIG-I, in human macrophages.

Highlights

► Hypercytokinemia contributes to the severity of influenza A virus infection. ► SOCS-1 and RIG-I are differentially induced by the A/H1N1 and seasonal strains. ► The pandemic A/H1N1 strain induces an overproduction of inflammatory mediators. ► The inflammatory-antiviral responses are regulated by viral-host related factors.

Introduction

The 2009 outbreak of swine-origin influenza A/H1N1 [1], [2] continues to affect many countries, having caused over 18,000 deaths worldwide [3]. A growing body of evidence supports the hypothesis that the development of severe pneumonia in patients with pandemic (pdm) A/H1N1 infection is associated with increased immune activation and immune complex deposition [4], [5]. Therefore, it is of great importance to understand the factors that determine the development of severe disease. In this regard, high levels of pro-inflammatory cytokines and chemokines have been detected in peripheral blood and lung tissue from patients with severe pneumonia associated to the pdm A/H1N1 infection [4], [6]. Even though cytokines, chemokines, and growth factors are required to control influenza virus infection, their overproduction in an uncontrolled inflammatory response can lead to lung tissue damage [4], [6], [7]. The suppressors of cytokine signaling (SOCS) are a family of proteins that down-regulate cytokine signaling [8], [9], [10], [11] by negatively regulating JAK/STAT-mediated signal transduction [9], [10], [11]. Experimental infection of A549 epithelial cells with seasonal influenza A virus up-regulates the expression of SOCS-1 and SOCS-3. These proteins regulate the immune response against influenza A viruses through a retinoid-inducible gene (RIG)-I/mitochondrial antiviral signaling protein (MAVS)/interferon (alpha and beta) receptor 1 (IFNAR1)-dependent pathway [12].

On the other hand, the combination of gene segments from North American and Eurasian swine lineages of the pdm A/H1N1 virus [13] create unique molecular structures [14], [15] that could regulate host immune responses differently than seasonal influenza strains, and contribute to the particular clinical presentation of pandemic influenza infections.

We therefore hypothesized that immune feedback or regulatory mechanisms that normally control host inflammatory responses to pathogens may be absent or impaired in severe pdm A/H1N1 infection, due to the virus itself.

To establish if particular patterns of gene expression and alterations of immune regulation are attributable to specific viral factors, we analyzed the whole genome expression patterns induced by the pdm A/H1N1 and A/PR/8/34 strains through microarray analysis of infected human macrophages and A549 cells. In addition, we performed in vitro assays of macrophages and A549 cells in order to evaluate the differences between the pdm A/H1N1 and A/PR/8/34 in their capacity to induce SOCS-1, SOCS-3, and the antiviral response molecule RIG-I, as well as the production of pro-inflammatory cytokines, chemokines and growth factors.

Section snippets

Ethics statement

The Institutional Review Board of the National Institute of Respiratory Diseases (INER) reviewed and approved this protocol (protocol number B27-10), under which all subjects were recruited. All subjects provided written informed consent, and authorized the storage of their samples at INER repositories for this and future studies.

Seasonal and pandemic A/H1N1 influenza virus isolation, identification, and propagation

Influenza pdm A/H1N1 virus isolates were obtained from patients with severe pneumonia, who signed an informed consent letter, during the 2009 outbreak in Mexico City,

Differential expression of antiviral immune response-related genes is induced by pandemic A/H1N1 and A/PR/8/34 strains

In order to compare the transcriptional profiles induced by different influenza A virus strains, we compared genome-wide expression induced by infection (10 h) with the pdm A/H1N1 and A/PR/8/34 viruses in macrophages and A549 cells using the exon array 1.0 ST. We also analyzed the gene expression profile of macrophages without virus infection (Mock at 10 h of infection) and the results were used as basal expression to determine the differences induced in the gene expression provoked by the

Discussion

In previous studies, elevated levels of pro-inflammatory cytokines and chemokines in blood and lung from patients with severe pneumonia associated with pdm A/H1N1 virus have been identified, suggesting that hypercytokinemia may contribute to the severity of the disease [4], [6].

Here, we analyzed the ability of pdm A/H1N1 and A/PR8/34 viruses to induce specific gene expression patterns in infected macrophages and A549 epithelial cells. These analyses allowed us to identify 130 genes

Acknowledgement

This work was supported by The Mexican National Council of Science and Technology (CONACYT) Grants [127002, 142364 CB-2010-155382 and E-1105].

References (37)

T. Naka et al.
Negative regulation of cytokine and TLR signalings by SOCS and others
Adv Immunol
(2005)
R. Nakagawa et al.
SOCS-1 participates in negative regulation of LPS responses
Immunity
(2002)
N.K. Sinha et al.
Evolutionary complexities of swine flu H1N1 gene sequences of 2009
Biochem Biophys Res Commun
(2009)
X.X. Yang et al.
Gene expression profiles comparison between 2009 pandemic and seasonal H1N1 influenza viruses in A549 cells
Biomed Environ Sci
(2010)
I. Kinjyo et al.
SOCS1/JAB is a negative regulator of LPS-induced macrophage activation
Immunity
(2002)
S. Gordon et al.
Alternative activation of macrophages: mechanism and functions
Immunity
(2010)
M. Liu et al.
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications
Cytokine Growth Factor Rev
(2011)
J. Rehwinkel et al.
RIG-I detects viral genomic RNA during negative-strand RNA virus infection
Cell
(2010)
M.U. Gack et al.
Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I
Cell Host Microb
(2009)
S.E. Lapinsky
Epidemic viral pneumonia
Curr Opin Infect Dis
(2010)

R. Perez-Padilla et al.

Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico

N Eng J Med

(2009)

Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza, E. Bautista, T....

J. Zúñiga et al.

Inflammatory profiles in severe pneumonia associated to the pandemic influenza A/H1N1 virus isolated in Mexico City

Autoimmunity

(2011)

A.C. Monsalvo et al.

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes

Nat Med

(2011)

J.F. Bermejo-Martin et al.

Host adaptive immunity deficiency in severe pandemic influenza

Crit Care

(2010)

D. Kobasa et al.

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

Nature

(2007)

T.A. Endo et al.

A new protein containing an SH2 domain that inhibits JAK kinases

Nature

(2005)

A. Yoshimura et al.

SOCS proteins, cytokine signalling and immune regulation

Nat Rev Immunol

(2007)

Cited by (30)

CCL5/CCR5 axis in human diseases and related treatments
2022, Genes and Diseases
To defense harmful stimuli or maintain the immune homeostasis, the body produces and recruits a superfamily of cytokines such as interleukins, interferons, chemokines etc. Among them, chemokines act as crucial regulators in defense systems. CCL5/CCR5 combination is known for facilitating inflammatory responses, as well as inducing the adhesion and migration of different T cell subsets in immune responses. In addition, recent studies have shown that the interaction between CCL5 and CCR5 is involved in various pathological processes including inflammation, chronic diseases, cancers as well as the infection of COVID-19. This review focuses on how CCL5/CCR5 axis participates in the pathological processes of different diseases and their relevant signaling pathways for the regulation of the axis. Moreover, we highlighted the gene therapy and chemotherapy studies for treating CCR5-related diseases, including the ongoing clinical trials. The barriers and perspectives for future application and translational research were also summarized.
Influence of adjuvants on the amount, specificity and functional activity of antibody response to human influenza vaccine in mice
2021, Molecular Immunology
Citation Excerpt :
The percentage of IgGs that recognized the globular head relative to total IIV was estimated dividing the optical density obtained from an ELISA assay using the globular head as the source of antigen vs. the optical density from a parallel ELISA assay using the complete vaccine as the antigen multiplied by 100. Human Influenza A H1N1pdm09 virus isolated at Instituto Nacional de Enfermedades Respiratorias (INER) during the 2009 outbreak in México (Ramirez-Martinez et al., 2013; Zuniga et al., 2011) was propagated in MDCK cells and the whole supernatant batch was aliquoted and frozen in liquid nitrogen until use. The virus was titrated to obtain the batch’s TCID50 (Kawaoka and Neumann, 2012; Spackman, 2012).
It’s been almost a century since immunologists started using adjuvants as tools to develop more effective vaccines. Despite the rising number of adjuvanted vaccines in the last decades, we still lack knowledge of the adjuvants’ effects on antibody response.
This study was aimed to test the effect of immunizing mice with the human Inactivated Influenza vaccine (IIV), either alone or combined with different widely used adjuvants on the specific antibody response induced. Differential levels of IgM and IgG subclasses were found with the different adjuvants tested. Higher levels of antibodies did not always correspond with a higher efficacy to interfere with the virus infectivity. Differences in neutralization properties are possibly mediated by the specificity of the repertoire of antibodies induced. The repertoire was studied using a phage display 7-mer peptide library to screen for epitopes/mimotopes recognized by serum pools from vaccinated mice. The selected phage clones included peptides that corresponded to conformational mimotopes since they have no homology with lineal sequences of the Influenza strains’ proteins. Five peptides were identified as recognized by sera from mice immunized with the IIV vaccine alone, including peptides from the hemagglutinin stalk domain, and by sera from mice immunized with the vaccine plus the different adjuvants employed. Adjuvants elicited a more diverse repertoire of epitope-recognizing antibodies that recognized epitopes of the HA recombinant globular head. Mimotopes were theoretically located at the neutralizing antigenic sites of the globular head of Influenza A H1N1pdm09, Influenza A H3N2, and Influenza B hemagglutinin.
This study illustrates how different adjuvants can modify the extent and quality of humoral immunity against the IIV vaccine and the effectiveness of vaccination.
Differentially expressed genes after viral haemorrhagic septicaemia virus infection in olive flounder (Paralichthys olivaceus)
2016, Veterinary Microbiology
A strain of viral haemorrhagic septicaemia virus (VHSV) was isolated from cultured olive flounder (Paralichthys olivaceus) during epizootics in South Korean. This strain showed high mortality to olive flounder in in vivo challenge experiment. The complete genomic RNA sequences were determined and phylogenetic analysis of the amino acid sequences of glycoprotein revealed that this isolate was grouped into genotype IVa of genus Novirhabdovirus. Expression profile of genes in olive flounder was analyzed at day 1 and day3 after infection with this VHSV isolate by using cDNA microarray containing olive flounder 13K cDNA clones. Microarray analysis revealed 785 up-regulated genes and 641 down-regulated genes by at least two-fold in virus-infected fish compared to healthy control groups. Among 785 up-regulated genes, we identified seven immune response-associated genes, including the interferon (IFN)-induced 56-kDa protein (IFI56), suppressor of cytokine signaling 1 (SOCS1), interleukin 8 (IL-8), cluster of differentiation 83 (CD83), α-globin (HBA), VHSV-induced protein-6 (VHSV6), and cluster of differentiation antigen 9 (CD9). Our results confirm previous reports that even virulent strain of VHSV induces expression of genes involved in protective immunity against VHSV.
Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice
2016, Antiviral Research
Influenza is a disease of the respiratory system caused by single stranded RNA viruses with varying genotypes. Immunopathogenesis to influenza viruses differs based on virus strain, dose, and mouse strain used in laboratory models. Although effective mucosal immune defenses are important in early host defense against influenza, information on the kinetics of these immune defense mechanisms during the course of influenza infection is limited. We investigated changes to antimicrobial peptides and primary innate immune cells at early time points after infection and compared these variables between two prominent H1N1 influenza A virus (IAV) strains, A/CA/04/2009 and A/PR/08/1934 in C57BL/6 mice. Alveolar and parenchymal macrophage ratios were altered after IAV infection and pro-inflammatory cytokine production in macrophages was induced after IAV infection. Genes encoding antimicrobial peptides, β-defensin (Defb4), bactericidal-permeability increasing protein (Bpifa1), and cathelicidin antimicrobial peptide (Camp), were differentially regulated after IAV infection and the kinetics of Defb4 expression differed in response to each virus strain. Beta-defensin reduced infectivity of A/CA/04/2009 virus but not A/PR/08/1934. Beta defensins also changed the innate immune cell profile wherein mice pre-treated with β-defensin had increased alveolar macrophages and CD103⁺ dendritic cells, and reduced CD11b⁺ dendritic cells and neutrophils. In addition to highlighting that immune responses may vary based on influenza virus strain used, our data suggest an important role for antimicrobial peptides in host defense against influenza virus.
Galectins regulate the inflammatory response in airway epithelial cells exposed to microbial neuraminidase by modulating the expression of SOCS1 and RIG1
2015, Molecular Immunology
Citation Excerpt :
SOCS1, a JAK binding protein, belongs to the SOCS family that is responsible for key negative feedback mechanisms to prevent uncontrolled inflammation (Croker et al., 2008). Upon IAV challenge, SOCS1 expression is upregulated through a RIG1/MAVS/IFNAR1-dependent pathway (Pothlichet et al., 2008), which suppresses expression of inflammatory cytokines, e.g., IL-6, TNF-α, IL-10, CCL3, CCL5, CCL4 and CXCL8, to prevent the cytokine storm (Ramirez-Martinez et al., 2013). Thus, upregulation of SOCS1 provides a negative feedback mechanism to set inflammation under control after pathogen clearance.
Influenza patients frequently display increased susceptibility to Streptococcus pneumoniae co-infection and sepsis, the prevalent cause of mortality during influenza pandemics. However, the detailed mechanisms by which an influenza infection predisposes patients to suffer pneumococcal pneumonia are not fully understood. A murine model for influenza infection closely reflects the observations in human patients, since if the animals that have recovered from influenza A virus (IAV) sublethal infection are challenged with S. pneumoniae, they undergo a usually fatal uncontrolled cytokine response. We have previously demonstrated both in vitro and in vivo that the expression and secretion of galectin-1 (Gal1) and galectin-3 (Gal3) are modulated during IAV infection, and that the viral neuraminidase unmasks galactosyl moieties in the airway epithelia. In this study we demonstrate in vitro that the binding of secreted Gal1 and Gal3 to the epithelial cell surface modulates the expression of SOCS1 and RIG1, and activation of ERK, AKT or JAK/STAT1 signaling pathways, leading to a disregulated expression and release of pro-inflammatory cytokines. Our results suggest that the activity of the viral and pneumococcal neuraminidases on the surface of the airway epithelial cells function as a “danger signal” that leads to rapid upregulation of SOCS1 expression to prevent an uncontrolled inflammatory response. The binding of extracellular Gal1 or Gal3 to the galactosyl moieties unmasked on the surface of airway epithelial cells can either “fine-tune” or severely disregulate this process, respectively, the latter potentially leading to hypercytokinemia.
Circulating levels of miR-150 are associated with poorer outcomes of A/H1N1 infection
2015, Experimental and Molecular Pathology
Citation Excerpt :
miRNAs have an important role in the regulation of many processes including inflammation in different clinical conditions (Perera and Ray, 2007). It is well known that uncontrolled immune inflammatory responses may contribute to the pathogenesis of severe lung damage in mice and humans with pandemic A/H1N1 virus infection (Zuniga et al., 2011; Bautista et al., 2013; Ubags et al., 2014; Ramirez-Martinez et al., 2013). In the current study we analyzed the circulating miRNA profiles and inflammatory mediators circulating levels in patients with different clinical presentations of the A/H1N1 infection and the most striking findings were: 1) high circulating levels of miR-150 are associated with severe A/H1N1 illness; 2) in experimental infection assays pandemic A/H1N1 induces higher levels of miR-150 than seasonal H3N2 strain; 3) miR-29c, miR-145 and miR-22 are differentially expressed in patients with severe A/H1N1 disease whereas miR-210, miR-126 and miRT-222 are downregulated in individuals exposed to the A/H1N1 virus; 4) there is a correlation between circulating levels of miR-150 with different pro-inflammatory mediators and growth factors including: IL-1b, IFN-γ, CXCL8 and G-CSF, particularly in critically ill A/H1N1 patients and 5) PI3K–Akt–mTOR, apoptosis, cancer and antiviral pathways are the most associated with the differentially expressed miRNAs in A/H1N1 infection.
Overproduction of pro-inflammatory cytokines and chemokines is frequently associated with severe clinical manifestations in patients infected with influenza A/H1N1 virus. Micro-RNAs (miRNAs) are highly conserved small non-coding RNA molecules that post-transcriptionally regulate gene expression and are potential biomarkers and therapeutic targets in different inflammatory conditions.
We studied the circulating and miRNA profiles in critically ill A/H1N1 patients, A/H1N1 patients with milder disease, asymptomatic housemates and healthy controls. Cytokine, chemokine and growth factors that were potential targets of differentially expressed miRNAs were assessed. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment and interactome analysis of these miRNAs were also performed.
Critically ill patients exhibited a significant over-expression of circulating miR-150 (p < 0.005) when compared to patients with milder disease. miR-29c, miR-145 and miR-22 were differentially expressed in patients with severe A/H1N1 disease whereas miR-210, miR-126 and miR-222 were downregulated in individuals exposed to the A/H1N1 virus. Significant correlations (p < 0.05) between circulating levels of miR-150 with IL-1ra, IL-2, IL-6, CXCL8, IFN-γ, CXCL10 and G-CSF were detected, particularly in critically ill patients.
The up-regulation of miR-150 is associated with poorer outcomes of A/H1N1 infection. The differential expression of miRNAs related with immune processes in severe A/H1N1 disease supports the potential role of these miRNAs as biomarkers of disease progression.

View all citing articles on Scopus

¹: These authors contributed equally to this work.

View full text

Seasonal and pandemic influenza H1N1 viruses induce differential expression of SOCS-1 and RIG-I genes and cytokine/chemokine production in macrophages

Abstract

Background

Methods

Results

Conclusions

Highlights

Introduction

Section snippets

Ethics statement

Seasonal and pandemic A/H1N1 influenza virus isolation, identification, and propagation

Differential expression of antiviral immune response-related genes is induced by pandemic A/H1N1 and A/PR/8/34 strains

Discussion

Acknowledgement

Adv Immunol

Immunity

Biochem Biophys Res Commun

Biomed Environ Sci

Immunity

Immunity

Cytokine Growth Factor Rev

Cell

Cell Host Microb

Epidemic viral pneumonia

Curr Opin Infect Dis

Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico

N Eng J Med

Inflammatory profiles in severe pneumonia associated to the pandemic influenza A/H1N1 virus isolated in Mexico City

Autoimmunity

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes

Nat Med

Host adaptive immunity deficiency in severe pandemic influenza

Crit Care

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

Nature

A new protein containing an SH2 domain that inhibits JAK kinases

Nature

SOCS proteins, cytokine signalling and immune regulation

Nat Rev Immunol